LKT Labs, 1174043-16-3

1 - 1 of 1
Sort
View
Show
  • LKT Labs

    AZD-2461 is a novel anticancer chemotherapeutic currently in clinical trials. This compound acts as a poly(ADP)-ribose polymerase-1 (PARP1) inhibitor, potentially beneficial in homologous recombination-deficient tumors such as BRCA1-associated cancers. Unlike most PARP inhibitors, AZD-2461 is not a…